Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL0DF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,401
Award facts
- Contract value 100% obligated
- $37,401.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $37,401 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body applicator units. The award was issued on November 24, 2025, with an ultimate completion date of December 16, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX prime indefinite delivery vehicle enables AmerisourceBergen to supply pharmaceutical products globally to support military healthcare programs, serving customers including the Defense Health Agency and U.S. Coast Guard, while the DLA Troop Support plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FL0DF?
SPE2DR26FL0DF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FL0DF worth?
The government has obligated $37,401 on SPE2DR26FL0DF.
Is contract SPE2DR26FL0DF an order under another contract?
Yes. SPE2DR26FL0DF is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL0DF competed?
The extent of competition for SPE2DR26FL0DF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award